Verification of an oro-antral communication after tooth extraction in the upper jaw. A Pilot-study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-012222-36-AT

Enrollment

Registered

2009-06-02

Start date

2009-07-23

Completion date

Unknown

Last updated

2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Jopamiro 370mg J/ml Product Name: Jopamiro 370mg J/ml Pharmaceutical Form: Gel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Tooth extraction of the upper molars Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - pregnant - allergy to radiopaque material

Design outcomes

Primary

Measure	Time frame
Main Objective: Verification of an oro-antral communication after tooth extraction in the upper jaw;Secondary Objective: ;Primary end point(s):	—

Countries

Austria

Outcome results